Article EMA Thank You What we expect European regulators to do in April 2024
Agency IQ
MARCH 29, 2024
regulatory framework Webinar/ Seminar ( OPEN ) EMA 4/17/2024 4/17/2024 CEP 2.0:
Biosimilars Drug Trials Trials 
40 
Article EMA Thank You What we expect European regulators to do in May 2024
Agency IQ
MAY 3, 2024
Two consultations on clinical trial considerations, one on advanced therapies and the other addressing non-inferiority and equivalence comparisons, are closing at the end of May. The pharma reform package remains in E.U. leaders’ eyesight as the Parliament winds down ahead of its June elections.
Recon: Sanofi, GKS report positive interim results for COVID shot; Regeneron resumes lymphoma trials
The Pharma Data
MAY 17, 2021
Regeneron resumes enrollment in lymphoma drug trials ( Reuters ). Incyte’s vitiligo treatment meets main goal in late-stage trial ( Reuters ). US Supreme Court denies Sandoz petition to review biosimilar Erelzi case ( Press ). Now they fear an increase. BioPharmaDive ).
Let's personalize your content